Mailhac, A., Pedersen, L., Pottegård, A., Søndergaard, J., Mogensen, T.
, Sørensen, H. T. & Thomsen, R. W. (2024).
Semaglutide (Ozempic®) Use in Denmark 2018 Through 2023 ‒ User Trends and off-Label Prescribing for Weight Loss.
Clinical epidemiology,
16, 307-318.
https://doi.org/10.2147/CLEP.S456170
Mahon, B. E.
, Ehrenstein, V., Nørgaard, M., Pedersen, L., Rothman, K. J.
& Sørensen, H. T. (2007).
Perinatal risk factors for hospitalization for pneumococcal disease in childhood: a population-based cohort study.
Pediatrics Electronic Pages,
119(4), e804-12.
https://doi.org/10.1542/peds.2006-2094
Mahmoudi, Z., Jensen, M. H., Dencker Johansen, M., Christensen, T. F.
, Tarnow, L., Christiansen, J. S. & Hejlesen, O. (2014).
Accuracy evaluation of a new real-time continuous glucose monitoring algorithm in hypoglycemia.
Diabetes Technology & Therapeutics,
16(10), 667-78.
https://doi.org/10.1089/dia.2014.0043
Mahmoudi, Z., Johansen, M. D., Nørgaard, H. H., Andersen, S., Pedersen-Bjergaard, U.
, Tarnow, L., Christiansen, J. S. & Hejlesen, O. (2015).
Effect of Continuous Glucose Monitoring Accuracy on Clinicians' Retrospective Decision Making in Diabetes: A Pilot Study.
Journal of Diabetes Science and Technology,
9(5), 1092-102.
https://doi.org/10.1177/1932296815587935
Mahic, M., Hernandez-Diaz, S., Wood, M., Kieler, H., Odsbu, I.
, Norgaard, M., Öztürk, B., Bateman, B. T., Hjellvik, V., Skurtveit, S. & Handal, M. (2020).
In utero opioid exposure and risk of infections in childhood: A multinational Nordic cohort study.
Pharmacoepidemiology and Drug Safety,
29(12), 1596-1604.
https://doi.org/10.1002/pds.5088
Magyari, M., Joensen, H., Kopp, T. I., Pontieri, L.
& Koch-Henriksen, N. (2022).
Changes in prognosis of the Danish multiple sclerosis population over time.
Multiple Sclerosis Journal,
28(14), 2190-2201.
https://doi.org/10.1177/13524585221110582
Mæng, M., Okkels Jensen, L.
, Kaltoft, A., Bøttcher, M., Hansen, H.-H. T., Johnsen, S. P., Pedersen, L., Sørensen, H. T., Rasmussen, K., Lassen, J. F., Thayssen, P.
& Thuesen, L. (2007).
Stent thrombosis, myocardial infarction, and mortality following drug-eluting and bare metal stent coronary interventions in patients with diabetes mellitus.
American Journal of Cardiology,
100(36L).
Mæng, M., Kaltoft, A., Jensen, L. O., Hansen, H.-H. T., Thayssen, P.
, Rasmussen, K., Christiansen, E. H., Madsen, M.
, Johnsen, S. P., Sørensen, H. T., Lassen, J. F. & Thuesen, L. (2008).
Western Denmark Heart Registry: A Large-scale Registry Examining the Safety and Efficacy of Zotarolimus-eluting and Sirolimus-eluting Stents in Patients with Coronary Artery Disease. Abstract from TCT 2008 (Transcatheter Therapeutics Congress), Washington, United States.
Mæng, M., Jensen, L. O., Kaltoft, A., Hansen, H.-H. T., Ravkilde, J., Thayssen, P.
, Bøtker, H. E., Christiansen, E. H., Madsen, M., Johnsen, S. P., Lassen, J. F. & Thuesen, L. (2009).
Safety and Effectiveness of Sirolimus and Zotarolimus-Eluting Stents in Diabetic and Non-diabetic Patients in Western Denmark.
American Journal of Cardiology, (6 Suppl), 14D.
Mæng, M., Jensen, L. O., Hansen, H.-H. T., Kaltoft, A., Thayssen, P.
, Ravkilde, J., Madsen, M., Sørensen, H. T., Thuesen, L. & Lassen, J. F. (2010).
Clinical outcome after coronary implantation of zotarolimus-eluting versus sirolimus-eluting stents in patients with diabetes mellitus: an 18-month Sort Out III substudy.
European Heart Journal Supplements,
31(s1), 926.
Mæng, M., Jensen, L. O., Hansen, H.-H. T., Kaltoft, A., Thayssen, P., Galløe, A. M.
, Christiansen, E. H., Kelbæk, H. S.
, Krusell, L. R., Ravkilde, J., Sørensen, H. T., Thuesen, L. & Lassen, J. F. (2010).
18 month clinical outcome after implantation of zotarolimus-eluting versus sirolimus-eluting stents in patients with diabetes - a SORT OUT III substudy. Poster session presented at TCT 2010, Washington DC, United States.
Mæng, M., Jensen, L. O., Hansen, H.-H. T., Kaltoft, A., Thayssen, P., Galløe, A. M.
, Christiansen, E. H., Kelbæk, H. S.
, Krusell, L. R., Ravkilde, J., Sørensen, H. T., Thuesen, L. & Lassen, J. F. (2010).
18 month clinical outcome after implantation of zotarolimus-eluting versus sirolimus-eluting stents in patients with diabetes - a SORT OUT III substudy.
Journal of the American College of Cardiology,
56(13 s1), B67.
Mæng, M., Thim, T., Ghisholm, G.
, Johansen, M. B., Schmidt, M., Sørensen, H. T., Jensen, L. O., Thayssen, P.
, Tilsted, H.-H., Bøtker, H. E., Lassen, J. F. & Thuesen, L. (2012).
Major Adverse Cardiac Events Associated With Discontinuation Of Clopidogrel Treatment Within The First Year After Coronary Stent Implantation In Western Denmark. J Am Coll Cardiol. 2012;60(17_S).
Maeng, M.
, Hansen, H.-H. T., Jensen, L. O., Kaltoft, A., Thayssen, P.
, Ravkilde, J., Christiansen, E., Madsen, M.
, Johnsen, S. P., Thuesen, L.
& Lassen, J. F. (2009).
Clinical Presentation of Restenosis and Definite Stent Thrombosis in Patients Treated with Zotarolimus and Sirolimus-Eluting Stents - An Analysis from the Western Denmark Heart Registry.
American Journal of Cardiology, (6 Suppl. 21. sept.), 146D.
Maeng, M., Jensen, L. O.
, Tilsted, H.-H., Kaltoft, A., Kelbaek, H., Abildgaard, U., Villadsen, A.
, Aarøe, J., Thayssen, P.
, Krusell, L. R., Christiansen, E. H., Bøtker, H. E., Kristensen, S. D., Ravkilde, J., Madsen, M., Sørensen, H. T., Rasmussen, K., Thuesen, L. & Lassen, J. F. (2011).
Outcome of Sirolimus-Eluting Versus Zotarolimus-Eluting Coronary Stent Implantation in Patients With and Without Diabetes Mellitus (a SORT OUT III Substudy).
American Journal of Cardiology,
108(9), 1232-7.
https://doi.org/10.1016/j.amjcard.2011.06.037
Maeng, M., Tilsted, H.-H., Jensen, L. O.
, Kaltoft, A., Kelbæk, H., Abildgaard, U.
, Boel Villadsen, A., Krusell, L. R., Ravkilde, J., Hansen, K. N.
, Christiansen, E. H., Aarøe, J., Jensen, J. S.
, Kristensen, S. D., Bøtker, H. E., Madsen, M., Thayssen, P., Sørensen, H. T.
, Thuesen, L. & Lassen, J. F. (2012).
3-Year Clinical Outcomes in the Randomized SORT OUT III Superiority Trial Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents.
JACC. Cardiovascular interventions,
5(8), 812-8.
https://doi.org/10.1016/j.jcin.2012.04.008
Maeng, M., Jensen, L. O.
, Kaltoft, A., Tilsted, H.-H., Christiansen, E. H., Thayssen, P.
, Madsen, M., Sørensen, H. T., Lassen, J. F. & Thuesen, L. (2012).
Comparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry.
B M C Cardiovascular Disorders,
12(1), 84.
https://doi.org/10.1186/1471-2261-12-84
Maeng, M., Tilsted, H.-H., Jensen, L. O., Krusell, L. R., Kaltoft, A., Kelbæk, H. S.
, Boel Villadsen, A., Ravkilde, J., Hansen, K. N.
, Christiansen, E. H., Aarøe, J., Jensen, J. S.
, Kristensen, S. D., Bøtker, H. E., Thuesen, L., Madsen, M., Thayssen, P.
, Sørensen, H. T. & Lassen, J. F. (2014).
Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial.
Lancet.
https://doi.org/10.1016/S0140-6736(14)60405-0
Maeng, M., Christiansen, E. H., Raungaard, B., Kahlert, J., Terkelsen, C. J., Kristensen, S. D., Carstensen, S., Aarøe, J., Jensen, S. E.
, Villadsen, A. B., Lassen, J. F., Thim, T., Eftekhari, A., Veien, K. T., Hansen, K. N., Junker, A.
, Bøtker, H. E., Jensen, L. O. & SORT OUT VIII Investigators (2019).
Everolimus-Eluting Versus Biolimus-Eluting Stents With Biodegradable Polymers in Unselected Patients Undergoing Percutaneous Coronary Intervention: A Randomized Noninferiority Trial With 1-Year Follow-Up (SORT OUT VIII Trial).
JACC: Cardiovascular Interventions,
12(7), 624-633.
https://doi.org/10.1016/j.jcin.2018.12.036,
https://doi.org/10.1016/j.jcin.2018.12.036
Maeng, C. V., Østgård, L. S. G., Christiansen, C. F. & Liu, K. D. (2021).
Changes in intensive care unit admission rates, organ support, and mortality in patients with acute myeloid leukaemia over a 12-year period: a Danish nationwide cohort study.
British Journal of Haematology,
195(1), 137-140.
https://doi.org/10.1111/bjh.17630
Maeng, C. V., Christiansen, C. F., Liu, K. D.
, Kamper, P., Christensen, S., Medeiros, B. C.
& Østgård, L. S. G. (2022).
Factors associated with risk and prognosis of intensive care unit admission in patients with acute leukemia: a Danish nationwide cohort study.
Leukemia and Lymphoma,
63(10), 2290-2300.
https://doi.org/10.1080/10428194.2022.2074984
Madsen, T. V., Leitner, T.
, Lohse, N., Obel, N., Ladefoged, K., Gerstoft, J., Petersen, A. B., Nielsen, C. & Jørgensen, L. B. (2007).
Introduction of HIV type 1 into an isolated population: molecular epidemiologic study from Greenland. AIDS Research and Human Retroviruses,
23(5), 675-81.
https://doi.org/10.1089/aid.2007.0235
Madsen, T. V.
, Lohse, N., Jensen, E. S., Obel, N., Ladefoged, K., Gerstoft, J., Petersen, A. B., Nielsen, C. & Jørgensen, L. B. (2008).
Short communication: high prevalence of drug-resistant human immunodeficiency virus type 1 in treatment-naïve patients in Greenland.
AIDS Research and Human Retroviruses,
24(8), 1073-7.
https://doi.org/10.1089/aid.2008.0049
Madsen, J., Nielsen, R.
, Engebjerg, M. C., Sørensen, H. T., Bukh, A. & d'Amore, F. A. (2010).
Use of statins and prognosis in patients with CD20-positive 'De Novo' diffuse large B cell lymphoma (DLBCL) treated with rituximab containing regimens. Poster session presented at 15th Congress of the European Hematology Association, Barcelona, Spain.
Madsen, J., Nielsen, R.
, Engebjerg, M. C., Sørensen, H. T., Bukh, A. & d'Amore, F. A. (2010).
Use of statins and prognosis in patients with CD20-positive 'De Novo' diffuse large B cell lymphoma (DLBCL) treated with rituximab containing regimens. Abstract from 15th Congress of the European Hematology Association, Barcelona, Spain.
Madsen, MM., Eiset, A. H., Mackenhauer, J., Odby, A.
, Christiansen, C. F., Kurland, L.
& Kirkegaard, H. (2016).
Selection of quality indicators for hospital-based emergency care in Denmark, informed by a modified-Delphi process.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine,
24(1), Article 11.
https://doi.org/10.1186/s13049-016-0203-x
Madsen, M.
, Nøhr, E. A., Olsen, J., Pisinger, C., Rod, N. H.
, Støvring, H. & Thomsen, R. W. (2013).
Vores vidensgrundlag er i fare.
Weekendavisen.
Madsen, N. L., Marino, B. S., Woo, J. G.
, Thomsen, RW., Videbœk, J., Laursen, H. B.
& Olsen, M. S. (2016).
Congenital Heart Disease With and Without Cyanotic Potential and the Long-term Risk of Diabetes Mellitus: A Population-Based Follow-up Study.
Journal of the American Heart Association,
5(7), Article e003076.
https://doi.org/10.1161/JAHA.115.003076
Madsen, N. L., Goldstein, S. L.
, Frøslev, T., Christiansen, C. F. & Olsen, M. (2017).
Cardiac surgery in patients with congenital heart disease is associated with acute kidney injury and the risk of chronic kidney disease.
Kidney International. Supplement,
92(3), 751-756.
https://doi.org/10.1016/j.kint.2017.02.021
Madsen, K. B., Ravn, M. H.
, Arnfred, J., Olsen, J., Rask, C. U. & Obel, C. (2018).
Characteristics of undiagnosed children with parent-reported ADHD behaviour.
European Child & Adolescent Psychiatry,
27(2), 149–158.
https://doi.org/10.1007/s00787-017-1029-4
Madsen, K. B., Hohwü, L., Zhu, J. L., Olsen, J. & Obel, C. (2020).
Social selection in cohort studies and later representation of childhood psychiatric diagnoses: The Danish National Birth Cohort.
Scandinavian Journal of Public Health,
48(2), 207-213.
https://doi.org/10.1177/1403494817726619
Madsen, K. B., Rask, C. U., Olsen, J., Niclasen, J.
& Obel, C. (2020).
Depression-related distortions in maternal reports of child behaviour problems.
European Child & Adolescent Psychiatry,
29(3), 275-285.
https://doi.org/10.1007/s00787-019-01351-3
Madsen, C. N., Henriksen, T. B., Ramlau-Hansen, C. H., Parner, E. T., Olsen, J. & Bech, B. H. (2020).
Coffee intake during pregnancy and childhood acute leukemia - A cohort study.
Cancer epidemiology,
67, Article 101747.
https://doi.org/10.1016/j.canep.2020.101747
Ma, Q.
, Wang, H., Rolls, E. T., Xiang, S.
, Li, J., Li, Y., Zhou, Q., Cheng, W. & Li, F. (2022).
Lower gestational age is associated with lower cortical volume and cognitive and educational performance in adolescence.
BMC Medicine,
20(1), Article 424.
https://doi.org/10.1186/s12916-022-02627-3
M, J., Riboli, E., Cleveland, R. J., Norat, T., Rinaldi, S., Nieters, A., Biessy, C., Tjønneland, A.
, Olsen, A. V., Overvad, K., Grønbæk, H., Clavel-Chapelon, F., Boutron-Ruault, M. C., Linseisen, J., Boeing, H., Pischon, T., Trichopoulos, D., Oikonomou, E., Trichopoulou, A. ... Kaaks, R. (2007).
Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. International Journal of Cancer,
121(2), 368-76.
Lynge, E., Beau, A.-B.
, Christiansen, P., von Euler-Chelpin, M., Kroman, N.
, Njor, S. & Vejborg, I. (2017).
Overdiagnosis in breast cancer screening: The impact of study design and calculations.
European Journal of Cancer,
80, 26-29.
https://doi.org/10.1016/j.ejca.2017.04.018
Lyngaa, T., Christiansen, C. F., Nielsen, H., Neergaard, M. A., Jensen, A. B., Laut, K. G. & Johnsen, S. P. (2015).
Intensive care at the end of life in patients dying due to non-cancer chronic diseases versus cancer: a nationwide study in Denmark.
Critical Care (Online Edition),
19, 413.
https://doi.org/10.1186/s13054-015-1124-1